Drugs / P. vivax irradiated sporozoites
last change Sep 2017 re-read 3 minutes ago

P. vivax irradiated sporozoites

Vaccine

Developed for
malaria
Investigated by
Asoclinic Inmunología Ltda. · Malaria Vaccine and Drug Development Center · National Heart, Lung, and Blood Institute (NHLBI)

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01082341 Jun 2012 → May 2015 malaria Malaria Vaccine and Drug Development Center Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as P. vivax irradiated sporozoites ClinicalTrials.gov intervention name — accepted as the source's own label NCT01082341 ↗
Modality Vaccine “P. vivax irradiated sporozoites vaccine” NCT01082341 ↗